日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Indole-3-propionic acid links gut dysfunction to diabetic retinopathy: a biomarker and novel therapeutic approach

吲哚-3-丙酸将肠道功能障碍与糖尿病视网膜病变联系起来:一种生物标志物和一种新的治疗方法

Prasad, Ram; Adu-Rutledge, Yvonne; Ziani, Borhane; Floyd, Jason L; Ready, Edgar L; Paul, Sarbodeep; Sheini, Fadeela; Sharma, Rati; Rosencrans, Robert F; Li Calzi, Sergio; Sielski, Micheli Severo; Medawar, Nicholas G; Dutta, Roshan; Johnson, Emory Brennis; Qi, Xiaoping; Bansal, Mohit; Lamendella, Regina; Wright, Justin R; Verma, Suresh Kumar; Boulton, Michael E; Stevens, Bruce R; Vander Kooi, Craig W; Sun, Ramon C; Oudit, Gavin Y; Li, Qiuhong; Grant, Maria B

Autonomous AI-assisted diabetic retinopathy screening at primary care is associated with increased presentation to eye care by at risk patients

在基层医疗机构开展的自主人工智能辅助糖尿病视网膜病变筛查与高危患者就诊眼科的增加相关

Leong, Ariel; Wolf, Risa M; Channa, Roomasa; Wang, Jiangxia; Lehmann, Harold; Abramoff, Michael D; Liu, T Y Alvin

Single-Cell RNA Sequencing of Retina Reveals Nna1 Upregulation in Myopic Diabetic Retinopathy as a Protective Factor Against Diabetic Damage

单细胞RNA测序揭示近视性糖尿病视网膜病变中Nna1上调是抵抗糖尿病损伤的保护因素

Xie, Lihui; Cai, Yingjun; Chen, Bolin; Li, Bowen; Zou, Jing; Xu, Huizhuo

Systemic targeting of aberrant neovascular tufts using trehalose-dendrimer nanocarriers for the treatment of proliferative retinopathies.

利用海藻糖-树状聚合物纳米载体系统性靶向异常新生血管簇治疗增殖性视网膜病变。

Rani Anu, Bisen Shivantika, Sharma Rishi, Dar Aqib Iqbal, Sharma Anamika, Dhull Anubhav, Palmer Nina, Goody Kenneth John, Singh Nikhlesh K, Sharma Anjali

ROS-responsive transmembrane peptide-antibody conjugate eyedrops for the non-invasive treatment of choroidoretinopathy

用于非侵入性治疗脉络膜视网膜病变的ROS响应性跨膜肽-抗体偶联物滴眼液

Qu, Lihang; Lu, Tu; Tan, Jun; Chen, Xinzhao; Tian, Tian; Liu, Shixiang; Gong, Yajun; Jiang, Zhihao; He, Zhonggui; Sun, Peng; Sun, Jin; Ma, Xiaoli; Gu, Ruidong

Association of HbA(1c) and an updated glucose management indicator (uGMI) with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study

糖化血红蛋白 (HbA1c) 和更新的血糖管理指标 (uGMI) 与 1 型糖尿病成人糖尿病视网膜病变发生率的相关性:一项纵向研究

Shah, Viral N; Xu, Yongjin; Dabiri, Yaghoub; Mohanadas, Hemanth P; Cheng, Alan; Dunn, Timothy C

Clinical trial landscape of diabetic retinopathy: global advancements and future directions

糖尿病视网膜病变临床试验概况:全球进展与未来方向

Cao, Haixing; Zhang, Yujie; Zhang, Naiwen; Ma, Xiang

Insulin-like growth factor-1 for the prevention or treatment of retinopathy of prematurity

胰岛素样生长因子-1用于预防或治疗早产儿视网膜病变

Trzaski, Jennifer M; Cracknell, Jane; Herbst, Katherine W; Iverson, Marissa G; Quinn, Graham E; Sink, David W; Hagadorn, James I

Telemedicine for diabetic retinopathy screening

远程医疗在糖尿病视网膜病变筛查中的应用

Shahbazian, Angela; Sherstinsky, Mark; Ison, Elysia M; Han, Genie; Kruoch, Zanna; Hatcher, Kensington; Lawrenson, John G

Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy: The CONDOR Randomized Clinical Trial

Brolucizumab治疗增殖性糖尿病视网膜病变:CONDOR随机临床试验

Wolf, Sebastian; Chen, Youxin; Li, Xiaorong; Shimura, Masahiko; Sakamoto, Taiji; Wykoff, Charles C; Emanuelli, Andres; Salehi-Had, Hani; Yan, Kang; Kovacic, Lidija; Kim, Yongsoo